<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01213758</url>
  </required_header>
  <id_info>
    <org_study_id>AarhusLiverRadGal</org_study_id>
    <nct_id>NCT01213758</nct_id>
  </id_info>
  <brief_title>Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT</brief_title>
  <official_title>Radiation Induced Change of Liver Function Measured by Uptake of the Galactose Analogue FDGal and PET/CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients treated with stereotactic radiotherapy for liver tumors undergo PET/CT using the
      galactose analogue 18-F-deoxy-galactose (FDGal) before and after radiotherapy. This technique
      provides volumetric mapping of liver function and it allows quantisation of liver function.
      The method may be used for selection of patients for stereotactic radiotherapy of liver
      tumors, for determination of radiation induced liver dysfunction and may be included into the
      treatment planning process of stereotactic radiotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Uptake of FDGal</measure>
    <time_frame>Before, 1 month and 3 months after stereotactic radiotherapy</time_frame>
    <description>Volumetric uptake of FDGal can be measured is measured by PET/CT</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">14</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <condition>Cholangiocarcinoma</condition>
  <condition>Metastases</condition>
  <condition>Stereotactic Body Radiotherapy</condition>
  <arm_group>
    <arm_group_label>Liver tumors</arm_group_label>
    <description>Patients where stereotactic body radiation therapy is planned for primary or metastatic liver tumors.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Measuring liver function by PET/CT</intervention_name>
    <description>Measuring liver function by use of FDGal and PET/CT before, 1 month and 3 months after stereotactic radiotherapy for liver tumors</description>
    <arm_group_label>Liver tumors</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with liver tumors reffered for stereotactic body radiation therapy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  liver tumor

          -  referred for stereotactic radiation therapy

          -  age &gt; 18 years

        Exclusion Criteria:

          -  Impaired kidney function

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morten HÃ¸yer, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.cirro.dk</url>
    <description>The Lundbeck Foundation Centre for Interventional Research in Radiation Oncology</description>
  </link>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2010</study_first_submitted>
  <study_first_submitted_qc>October 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2010</study_first_posted>
  <last_update_submitted>October 27, 2017</last_update_submitted>
  <last_update_submitted_qc>October 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver function</keyword>
  <keyword>galactose</keyword>
  <keyword>18-F-deoxy-galactose</keyword>
  <keyword>PET/CT</keyword>
  <keyword>stereotactic body radiation therapy</keyword>
  <keyword>SBRT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Cholangiocarcinoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

